NRNP 6559 Week 4 Uterine Bleeding Workup Example

Advanced Primary Care of Women and Diverse Populations Walden University Free custom sample in 24 to 48h

This NRNP 6559 Week 4 abnormal uterine bleeding workup example evaluates a composite 42-year-old warehouse supervisor whose periods changed over the past year from every 35 to 60 days to every 20 to 24 days, with nine days of flow and heavy product use. Bleeding is quantified, a bleeding disorder screen is applied, and examination finds an irregular, enlarged uterus. Causes are sorted by PALM-COEIN, with fibroids and ovulatory dysfunction leading. Testing comes in three stages, and endometrial sampling is argued from her age and years of irregular cycles rather than simply ordered. Her options are discussed with her work schedule in mind. Walden NRNP 6559, Advanced Primary Care of Women and Diverse Populations, scores MSN nurse practitioner students mainly on classification and sequencing. Sources include FIGO's PALM-COEIN system and ACOG guidance on abnormal uterine bleeding.

CourseNRNP 6559 Advanced Primary Care of Women and Diverse Populations
WeekWeek 4
Paper typeAbnormal uterine bleeding workup
LengthAbout 820 words, 5 pages
FormatAPA 7 student paper
SchoolWalden University
ProgramMaster of Science in Nursing (MSN)
UpdatedOctober 2026

Free sample paper for NRNP 6559 Week 4

1

Abnormal Uterine Bleeding Workup: A 42-Year-Old With Heavy, Frequent Bleeding, an Irregular Uterus, and Years of Irregular Cycles

Student Name

College of Nursing, Walden University

NRNP 6559: Advanced Primary Care of Women and Diverse Populations

Instructor Name

Month Day, Year

What this page is doingThe title carries the three findings that shape the workup: the bleeding pattern, the exam, and the history that bears on the endometrium. Each maps to a stage of testing below.
2

Abnormal Uterine Bleeding Workup: A 42-Year-Old With Heavy, Frequent Bleeding, an Irregular Uterus, and Years of Irregular Cycles

Bleeding, Quantified

Composite case. A 42-year-old warehouse supervisor reports that her periods have changed over the past year. Cycle length now: every 20 to 24 days; a year ago: every 35 to 60 days, as it had been since her twenties. Days of flow: 9, up from 5. Products: on the heaviest 3 days, she changes an overnight pad every 1 to 2 hours during a 10-hour shift and wears two pads at night. Clots larger than a quarter on those days. Flooding through her clothes at night twice in the past 3 months. One episode of spotting for 3 days in the middle of a cycle, 6 weeks ago. No bleeding after intercourse. Gravida 2, para 2, both vaginal births; tubal ligation after her second child.

A Bleeding Disorder Screen

A structured screen for an inherited bleeding disorder was used, built on the questions that best identified women with menorrhagia who had a laboratory bleeding disorder in its development study (Philipp et al., 2008). Heavy bleeding since her first period: no. Family history of a diagnosed bleeding disorder: no. Prolonged bleeding after tooth extraction, surgery, or childbirth: no; no transfusion after either birth. Past treatment for anemia: no. Result: negative.

Consequences of the bleeding: fatigue that makes her sit down during her shift; lightheadedness when she stands up fast; and, for 2 months, an urge to crunch ice, a classic sign of iron deficiency.

Risk factors bearing on the endometrium: irregular, infrequent cycles for two decades, which means long stretches of estrogen exposure without regular progesterone; body mass index 37.

Examination

Blood pressure 128/80, heart rate 96 lying and 110 standing. Conjunctival pallor. Thyroid not enlarged. No hirsutism or acanthosis. Speculum: small amount of dark blood at the os, cervix appears normal. Bimanual: uterus enlarged to about 12 weeks' size, firm, with an irregular contour on the right fundus; no adnexal masses; nontender.

Sorted by PALM-COEIN

The FIGO classification sorts causes into structural (PALM) and nonstructural (COEIN) groups (Munro et al., 2018). Applied to her:

Polyp: possible; intermenstrual spotting fits.

Adenomyosis: possible; an enlarged uterus fits, but her exam is irregular rather than globular.

Leiomyoma: likely; an enlarged, irregular uterus is the classic finding.

Malignancy and hyperplasia: must be excluded; two decades of irregular ovulation and obesity are risk factors for endometrial hyperplasia.

Coagulopathy: screen negative; not pursued further unless other testing is unrevealing.

Ovulatory dysfunction: supported by her long history of irregular cycles, although her recent cycles are frequent rather than infrequent.

Endometrial: a diagnosis of exclusion.

Iatrogenic: none; no anticoagulants, hormones, or IUD.

Not otherwise classified: none suspected.

More than one category can apply at once, and in her case leiomyoma and ovulatory dysfunction may coexist, with hyperplasia still to be ruled out.

What this page is doingThe framework is applied visibly, one category at a time, with her findings placed in each. Naming causes without the classification is where most bleeding workups lose credit.
3

Three Stages of Testing

Stage 1, today: urine pregnancy test; complete blood count; ferritin; thyroid-stimulating hormone. Results that would change the next step: a hemoglobin below 8 g/dL or ongoing orthostatic symptoms would move her to same-day evaluation for transfusion or intravenous iron before any other testing; an abnormal TSH would be treated and the bleeding reassessed.

Stage 2, within 2 weeks: transvaginal pelvic ultrasound, ordered because the uterus is enlarged and irregular on exam. Results that would change the next step: a fibroid distorting the cavity or a suspected polyp would lead to saline infusion sonohysterography or hysteroscopy, and would rule out an IUD as her treatment; a thickened or irregular endometrium would make stage 3 urgent.

Stage 3, at the stage 2 visit: endometrial biopsy in the office. ACOG's practice bulletin places endometrial sampling as a first-line test in women older than 45 with abnormal bleeding and in younger women with a history of unopposed estrogen exposure, such as obesity or chronic anovulation, as well as when bleeding persists or medical management fails (American College of Obstetricians and Gynecologists, 2012). She is 42, but two decades of anovulatory cycles and a body mass index of 37 place her in the second group. The ultrasound does not cancel the biopsy, whatever it shows. A result showing hyperplasia with atypia would lead to gynecology referral for definitive management.

Her Route, Her Options

Her priorities: to stop flooding at work, to keep working, and to avoid surgery if she can. She does not need contraception after her tubal ligation. Options discussed in principle, to be chosen once the ultrasound and biopsy are back: a levonorgestrel IUD if the cavity is not distorted, which also protects the endometrium; tranexamic acid on heavy days, which does not affect the endometrium; a progestin taken by mouth; and, if fibroids are large or distorting, referral to discuss uterine artery embolization or surgery. Iron replacement started today regardless of route. She chose to start tranexamic acid on her heavy days now, while the workup proceeds, and to decide on a longer-term option once the results are back.

References

American College of Obstetricians and Gynecologists. (2012). Practice bulletin no. 128: Diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstetrics & Gynecology, 120(1), 197-206. https://doi.org/10.1097/AOG.0b013e318262e320

Munro, M. G., Critchley, H. O. D., Fraser, I. S., & FIGO Menstrual Disorders Committee. (2018). The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. International Journal of Gynecology & Obstetrics, 143(3), 393-408. https://doi.org/10.1002/ijgo.12666

Philipp, C. S., Faiz, A., Dowling, N. F., Beckman, M., Owens, S., Ayers, C., & Bachmann, G. (2008). Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation. American Journal of Obstetrics and Gynecology, 198(2), 163.e1-163.e8. https://doi.org/10.1016/j.ajog.2007.08.070

NRNP 6559 Week 4 instructions, in plain terms

Week 4 of NRNP 6559 commonly asks for a workup of abnormal uterine bleeding. You quantify bleeding, screen for bleeding disorders, examine, classify causes with PALM-COEIN, sequence testing and discuss options with the patient. Faculty score classification and sequencing. Cite FIGO and ACOG in APA 7. Endometrial sampling should be justified by risk. Anemia should be assessed. Work and life factors influence options. NRNP 6559 faculty want bleeding quantified with cycle length, days of flow and product use. Apply a bleeding disorder screen. Sort causes with PALM-COEIN. Sequence testing in stages. Argue endometrial sampling from risk factors. Discuss options with her schedule in mind.

Inside the NRNP 6559 Week 4 example

A bleeding history comes first and is specific: cycle length now and a year ago, days of flow, products changed per shift, clots, flooding at night, and one episode of bleeding between cycles. A structured screen for an inherited bleeding disorder follows, along with fatigue, lightheadedness on standing, and a craving for ice. Her history of irregular cycles since her twenties and her weight are noted as risk factors bearing on the endometrium. Exam findings include an enlarged, irregular uterus on bimanual exam. Then the workup, in stages. Stage one holds a pregnancy test, blood count, iron studies, and thyroid function. Stage two is transvaginal ultrasound, ordered because the uterus was irregular. Stage three, endometrial sampling, is argued from her risk factors and ACOG guidance. Each stage names the result that would change the next.

Where the marks sit in the NRNP 6559 Week 4 rubric

Classification and sequencing do most of the scoring in a bleeding workup. A document that lists fibroids, polyps, and hormones in no particular order has named causes without the framework the course teaches, and PALM-COEIN applied visibly is where the credit is won here. Sequencing is marked next: ordering every test on day one reads as indiscriminate, while staged testing with stated triggers shows reasoning a grader can follow. Safety carries weight in a woman in the perimenopausal years, and a plan silent on endometrial sampling, or one that dismisses it without reasoning, loses points even if the likeliest cause is benign. Anemia screening is expected given her fatigue and ice craving. A pregnancy test missing from stage one draws a standard deduction, and context left out of the plan costs credit in this course specifically.

NRNP 6559 Week 4 help from the desk

Bleeding workups lose credit when causes are listed in no order. Use PALM-COEIN. Another common gap is skipping a bleeding disorder screen. Apply one. Writers also order endometrial sampling without justification. Argue it from risk. Avoid forgetting a pregnancy test. Check ferritin and hemoglobin. Keep cycle data consistent. Close with options that fit her life. Writers also skip her blood count and iron stores, though heavy flow may already need treatment. Order a CBC and ferritin. Another frequent slip is skipping the pregnancy test. Include it first. Writers sometimes list options without asking what she wants. Ask about her goals, including fertility. Keep the cycle data consistent. Close with follow-up after results.

Get a NRNP 6559 Week 4 example written to your instructions

Send what your Week 4 prompt supplies, the menstrual complaint, the history, and the rubric. A workup is drafted that classifies the bleeding with PALM-COEIN, stages investigations with a trigger for each step, and carries her context into the plan. No cost attaches to a first custom sample; turnaround is 24-48 hours.

More NRNP 6559 papers and MSN samples

NRNP 6559 Week 4 questions, answered

What is PALM-COEIN?

A classification system from FIGO, the International Federation of Gynecology and Obstetrics, for abnormal uterine bleeding in nonpregnant women of reproductive age. PALM groups structural causes that imaging or tissue can show; COEIN groups nonstructural causes. The example uses it to organize the differential, so each candidate cause sits in a recognized category and the workup can target structural and nonstructural questions separately.

Why is endometrial sampling argued rather than simply ordered?

Because it is invasive and not every woman with heavy bleeding needs it, yet missing hyperplasia or cancer in a woman at risk is a serious error. ACOG guidance identifies who should have tissue sampled, based on age and risk factors such as long-standing anovulation and obesity. The example applies that guidance to her history and states why she qualifies.

Why does her job appear in a gynecology workup?

Because this course asks for plans that fit the person. A carrier who cannot reach a bathroom for hours experiences heavy bleeding as a work problem, and that changes which management options are realistic and how quickly relief matters. The example records the detail in the history and returns to it in the plan, which is the visible adjustment rubrics here look for.

Where can I find a free NRNP 6559 Week 4 sample paper?

The 42-year-old's bleeding workup is reproduced here with the quantified bleeding, the disorder screen, PALM-COEIN sorting, staged testing and her options.

Which causes lead in NRNP 6559 Week 4?

Fibroids and ovulatory dysfunction, sorted with the PALM-COEIN system after an enlarged, irregular uterus is found.